Guidance in the Red / Amber List serves ONLY to define where clinical and prescribing responsibility for the listed medicines should lie in terms of governance and safety.
- Inclusion in this list does NOT imply the medicine has been accepted for use via Managed Entry, does NOT imply endorsement of use, and does NOT take account of the cost implications of use of a particular medicine.
- Prescribers should use this list in conjunction with guidance on the Managed entry process for medicines, and the NI formulary which includes information on current cost effective choices.
- As far as possible, new specialist medicines are added to the list at the point when they are granted a UK product licence. In some instances this may be prior to the medicine being launched.
The table below lists specialist medicines. Users should search by generic name where possible. Brand names listed are not exhaustive.
Show All Entries A-B C-D E-J K-M N-R S-Z
Approved Name | Example Trade Names | Context | Status | Guidance | New Entry |
---|---|---|---|---|---|
Nabilone | Red | ||||
Nafarelin | Synarel | When used for treatment of infertility | Red | ||
Naltrexone | Nalorex | Amber | No Shared Care Guideline Required (Click for info) | ||
NaMuscla® | Myotonia | Red | |||
Natalizumab | Tysabri | Red | |||
Necitumumab | Portrazza | Red | |||
Neratinib | Nerlynx | Red | |||
Nevirapine | Viramune | Red | |||
Nilotinib | Tasigna | Red | |||
Nintedanib | Vargatef , Ofev | Red | |||
Niraparib | Zejula | Red | |||
Nivolumab | Opdivo | Red | |||
Nusinersen | Spinraza | Red | |||
Obinutuzumab | Gazyvaro | Red | |||
Ocrelizumab | Ocrevus | Red | |||
Ocriplasmin | Jetrea | Red | |||
Octocog alfa | Advate | Red | |||
Octreotide | Sandostatin | Palliative Care | Amber | Octreotide Palliative Care Shared Care Guideline | |
Octreotide | Sandostatin | Neuroendocrine tumours and acromegaly. Within licence. | Amber | Octreotide Endocrinology Shared Care Guideline | |
Octreotide | Sandostatin | Outside licence (except Palliative Care) | Red | ||
Odevixibat | Bylvay | Red | |||
Ofatumumab | Kesimpta | Red | |||
Olanzapine Long Acting Injection | Zypadhera | Red | |||
Olaparib | Lynparza | Red | |||
Olaratumab | Red | ||||
Omalizumab | Xolair | Red | |||
Osimertinib | Tagrisso | Red | |||
Ozanimod | Zeposia | Red | |||
Paclitaxel | Red | ||||
Padeliporfin | Tookad | Red | |||
Palbociclib | Ibrance | Red | |||
Palivizumab | Synagis | Red | |||
Pamidronate Disodium | Aredia | Red | |||
Panobinostat | Farydak | Red | |||
Parathyroid hormone subcutaneous injection | Preotact | Red | |||
Paritaprevir + ritonavir + ombitasvir | Viekirax | Red | |||
Paritaprevir + ritonavir + ombitasvir +/- dasabuvir | Red | ||||
Pasireotide | Signifor | Red | |||
Patisiran | Onpattro | Red | |||
Pazopanib | Votrient | Red | |||
Pegaspargase | Oncaspar | Red | |||
Pegcetacoplan | Aspaveli | Red | |||
Pegfilgrastim | Neulasta | Red | |||
Peginterferon alfa | PegIntron, ViraferonPeg, Pegasys | Red | |||
Peginterferon beta-1a | Plegridy | Red | |||
Pegloticase | Krystexxa | Red | |||
Pegvaliase | Palynziq | Red | |||
Pegvisomant | Somavert | Red | |||
Pembrolizumab | Kytruda | Red | |||
Pemigatinib | Pemazyre | Red | |||
Penicillamine | Distamine | Amber | Penicillamine Shared Care Guideline | ||
Pentosan polysulfate sodium | Red | ||||
Pertuzumab | Perjeta | Red | |||
Phenelzine | Nardil | Amber | No Shared Care Guideline Required (Click for info) | ||
Phenylbutazone | Butacote | Red | |||
Pirfenidone | Esbriet | Red | |||
Pixantrone | Pixuvri | Red | |||
Plerixafor | Mozobil | Red | |||
Polatuzumab | Polivy | Red | |||
Pomalidomide | Imnovid | Red | |||
Ponatinib | Iclusig | Red | |||
Ponesimod | Ponvory | Red | |||
Posaconazole | Noxafil | Red | |||
Pralsetinib | Gavreto | Red | |||
Procarbazine | Red | ||||
Radium | Xofigo | Red | |||
Raltegravir | Isentress | Red | |||
Raltegravir + lamivudine | Dutrebis | Red | |||
Ramucirumab | Cyramza | Red | |||
Ranibizumab | Lucentis | Red | |||
Ravulizumab | Ultomiris | Red | |||
Regorafenib | Stivarga | Red | |||
Reslizumab | Cinqaero | Red | |||
Ribavirin | Rebetol, Virazole, Copegus | Red | |||
Ribociclib | Kisqali | Red | |||
Rilpivirine | Edurant | Red | |||
Riluzole | Rilutek | Amber | Riluzole Shared Care Guideline | ||
Riociguat | Adempas | Red | |||
Ripretinib | Quinlock | Red | |||
Risankizumab | Skyrizi | Red | |||
Risdiplam | Evrysdi | Red | |||
Ritonavir | Norvir | Red | |||
Rituximab | MabThera | Red | |||
Romiplostim injection | Nplate | Red | |||
Romosozumab | Red | ||||
Ropeginterferon alfa-2b | Besremi | ||||
Roxadustat | Evrenzo | Red | |||
Rucaparib | Rucaparib | Red | |||
Ruxolitinib | Jakavi | Red |